For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on January 7th, 2025 | 06:50 CET
RESCUE for Lilium!? HYDROGEN WINNERS dynaCERT and thyssenkrupp nucera instead of Nel and Plug Power Share!
dynaCERT and thyssenkrupp nucera have emerged as new hydrogen favourites in the past year. dynaCERT's shares almost doubled in the second half of the year, and there is a good chance that a new multi-year high will be reached in 2025. The technology is convincing customers, and new major orders would justify a revaluation. thyssenkrupp nucera has already proven that it can operate profitably - a milestone that former favourites Nel and Plug Power have yet to achieve. Similarly, Lilium filed for insolvency just before Christmas, but now investors, including Frank Thelen, are expected to inject millions. Is this the rescue?
Read
Commented by Fabian Lorenz on January 2nd, 2025 | 07:15 CET
MOMENTUM stocks for 2025: Rheinmetall, Bayer, Almonty Industries - Should you buy now?
Rheinmetall and Almonty Industries are entering the new year with momentum and are on the hunt for new all-time highs: Almonty is one of the strong performers in the commodities sector in 2024, and 2025 should be even better. The Company plans to bring the largest tungsten mine outside of China into production. Based on the explosion in sales and profits in the coming years, analysts see more than 200% upside potential. Things are also going well at Rheinmetall. The defense company plans to double its profit by 2027, suggesting the stock is not expensive. However, there is also potential for a setback. Unfortunately, Bayer experienced only downward momentum in 2024. Is a turnaround in sight for the once-largest DAX company?
Read
Commented by Fabian Lorenz on January 2nd, 2025 | 07:05 CET
+500% return in 2025 with D-Wave, Plug Power, or BMW partner European Lithium stock?
500% price gain in 2 months! This is extraordinary but possible, as D-Wave's share price demonstrated at the end of 2024. Analysts believe that European Lithium's share price is capable of a similar price jump. Maybe not in 2 months, but there is massive upside potential expected by March. Experts believe that lithium can make a comeback in the new year. BMW partner European Lithium, with deposits in Austria and Ireland, should benefit from this. Additionally, the Company has other valuable resources, including rare earth elements. Plug Power shareholders are hoping for a hydrogen comeback. Can the turnaround succeed, or is insolvency looming at the start of the year? By contrast, quantum computing is likely to continue to electrify the stock market in the new year. So, will the rally continue for D-Wave & Co.?
Read
Commented by Fabian Lorenz on December 27th, 2024 | 07:40 CET
MicroStrategy buys Bitcoin! Nel ASA halved! F3 Uranium ultra-high grade!
The Bitcoin super-bull has struck again just before Christmas. MicroStrategy purchased an additional 5,262 Bitcoins, with an average price exceeding USD 100,000. However, the potential for a setback is increasing. The story is different for F3 Uranium, where new drilling results are described as "'ultra-high grade"'! This seems to prove analysts right. They see the fair value of the uranium explorer's shares as almost 200% higher than its current level. In contrast, experts have halved their price target for Nel ASA shares. For them, the former hydrogen high-flyer is no longer a buy, as the industry faces serious problems.
Read
Commented by Fabian Lorenz on December 27th, 2024 | 07:30 CET
Renk electric tanks with Rheinmetall? Buy Nordex shares? XXIX Metal profits!
Is electric mobility coming to the battlefield soon? This is likely to be only a matter of time. For example, Renk is already working on hybrid models that are expected to offer clear advantages in the field and could also be used to electrify Rheinmetall tanks in the future. In addition, the new transmissions pave the way for autonomous driving tanks. Electric vehicles are driving the demand for copper just as much as artificial intelligence and renewable energies. XXIX Metal is benefiting from this. The Company emerged from a merger this year and has become a leading player. The copper content of the projects, which already exists, is convincing. And what is Nordex doing? The wind turbine manufacturer has reported a new order. The stock has remained relatively stable throughout 2024. Analysts see upside potential, but there are also risks.
Read
Commented by Fabian Lorenz on December 27th, 2024 | 07:20 CET
STOCK FAVOURITES 2025: Will Rheinmetall, TUI and Power Nickel continue their price rally?
Will Rheinmetall soon be supplying warships and submarines as well? This is entirely possible and would further fill the already bulging order books. However, risks are also looming. At Power Nickel, the revaluation began impressively in 2024. The stock still appears to have plenty of significant upside potential, as the Company not only has large deposits of nickel and copper but also palladium, gold, and silver. Strong news flow is expected in 2025. And what about TUI? The stock has held above the EUR 8 mark after the figures. Management is optimistic about the coming year.
Read
Commented by Fabian Lorenz on December 23rd, 2024 | 08:25 CET
SHARE PRICE RALLY 2025 or cash in? Siemens Energy, thyssenkrupp nucera, Myriad Uranium
Will the Siemens Energy share continue its price rally in 2025? This year, the Siemens Energy share was the top performer in the DAX. The problems in the wind sector were outshone by the boom in the gas and grid business. Now, the major shareholder wants to cash in! What do analysts say? The chances are good that the rally will continue for Myriad Uranium. The newsflow is positive, analysts see a lot of potential, and a capital increase was easily placed. Analysts are divided on the upside potential for thyssenkrupp nucera. Is a 100% rally possible for the German hydrogen hopeful?
Read
Commented by Fabian Lorenz on December 23rd, 2024 | 08:05 CET
Takeover candidates 2025: Plug Power, Evotec, Desert Gold
Will Plug Power be taken over, or is there a risk of a sharp drop in the share price? The latter is possible in the coming weeks, and shareholders must be careful. A hot takeover candidate in the gold sector is Desert Gold. Analysts see significant upside potential, and the Company is convincing with an exciting mix: production is expected to start in 2025, the resource has increased to 2 million ounces, and gold producers with deep pockets are active in the neighbourhood. At Evotec, a takeover attempt – albeit an amateurish one – has already failed this year. Will financial investor Triton make a serious bid in 2025, or will Deutsche Bank prove right with a target price of EUR 4?
Read
Commented by Fabian Lorenz on December 20th, 2024 | 08:00 CET
CAUTION advised for Rheinmetall! COMEBACK for Bayer and Saturn Oil + Gas?
Christmas came a week early for Rheinmetall. Germany's largest defense company has secured further orders worth EUR 1.7 billion. However, investors are reacting cautiously, as a slump could be imminent. In contrast, the downside risk for Saturn Oil & Gas appears limited, with significant upside potential. As one of North America's most cost-effective oil producers, Saturn aims to generate total free cash flow of up to CAD 475 million over three years. Analysts’ targets represent a tripling of the share price. And what is Bayer doing? The Leverkusen-based company is trading close to its multi-year low. However, one analyst outlines an interesting scenario.
Read
Commented by Fabian Lorenz on December 19th, 2024 | 07:00 CET
Evotec, Rheinmetall, Vidac Pharma: Buy recommendation, cancer revolution, or price collapse?
Analysts see significant potential for multiplication with Vidac Pharma's stock. It has already been one of the standout performers in the biotech sector in the second half of the year. The Company aims to revolutionize cancer treatment and has published the next top news. Analysts also see further price potential for Rheinmetall. However, shareholders should brace themselves for a possible significant correction in the share price of Germany's largest defense contractor. By contrast, opinions on Evotec remain divided. Is the share price at risk of halving again after a year to forget? Or is now the time to buy in?
Read